These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 39374557)

  • 1. Advances in designing ternary complexes: Integrating in-silico and biochemical methods for PROTAC optimisation in target protein degradation.
    Shaik S; Kumar Reddy Gayam P; Chaudhary M; Singh G; Pai A
    Bioorg Chem; 2024 Oct; 153():107868. PubMed ID: 39374557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling the CRL4A ligase complex to predict target protein ubiquitination induced by cereblon-recruiting PROTACs.
    Bai N; Riching KM; Makaju A; Wu H; Acker TM; Ou SC; Zhang Y; Shen X; Bulloch DN; Rui H; Gibson BW; Daniels DL; Urh M; Rock BM; Humphreys SC
    J Biol Chem; 2022 Apr; 298(4):101653. PubMed ID: 35101445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic and Structural Features of PROTAC Ternary Complexes.
    Casement R; Bond A; Craigon C; Ciulli A
    Methods Mol Biol; 2021; 2365():79-113. PubMed ID: 34432240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Developments in PROTAC-Mediated Protein Degradation: From Bench to Clinic.
    Hu Z; Crews CM
    Chembiochem; 2022 Jan; 23(2):e202100270. PubMed ID: 34494353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assays and technologies for developing proteolysis targeting chimera degraders.
    Liu X; Zhang X; Lv D; Yuan Y; Zheng G; Zhou D
    Future Med Chem; 2020 Jun; 12(12):1155-1179. PubMed ID: 32431173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Native Mass Spectrometry Can Effectively Predict PROTAC Efficacy.
    Beveridge R; Kessler D; Rumpel K; Ettmayer P; Meinhart A; Clausen T
    ACS Cent Sci; 2020 Jul; 6(7):1223-1230. PubMed ID: 32724856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PROTAC-induced Protein Functional Dynamics in Targeted Protein Degradation.
    Chang CA; Wu KY; Hung TI
    bioRxiv; 2024 Jun; ():. PubMed ID: 38746111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics.
    Khan S; He Y; Zhang X; Yuan Y; Pu S; Kong Q; Zheng G; Zhou D
    Oncogene; 2020 Jun; 39(26):4909-4924. PubMed ID: 32475992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic Detection of E3:PROTAC:Target Ternary Complexes Using NanoBRET Technology in Live Cells.
    Mahan SD; Riching KM; Urh M; Daniels DL
    Methods Mol Biol; 2021; 2365():151-171. PubMed ID: 34432243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PROTACs: past, present and future.
    Li K; Crews CM
    Chem Soc Rev; 2022 Jun; 51(12):5214-5236. PubMed ID: 35671157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PRosettaC: Rosetta Based Modeling of PROTAC Mediated Ternary Complexes.
    Zaidman D; Prilusky J; London N
    J Chem Inf Model; 2020 Oct; 60(10):4894-4903. PubMed ID: 32976709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Accuracy Prediction of PROTAC Complex Structures.
    Ignatov M; Jindal A; Kotelnikov S; Beglov D; Posternak G; Tang X; Maisonneuve P; Poda G; Batey RA; Sicheri F; Whitty A; Tonge PJ; Vajda S; Kozakov D
    J Am Chem Soc; 2023 Apr; 145(13):7123-7135. PubMed ID: 36961978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PROTAC-DB 2.0: an updated database of PROTACs.
    Weng G; Cai X; Cao D; Du H; Shen C; Deng Y; He Q; Yang B; Li D; Hou T
    Nucleic Acids Res; 2023 Jan; 51(D1):D1367-D1372. PubMed ID: 36300631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interplay of PROTAC Complex Dynamics for Undruggable Targets: Insights into Ternary Complex Behavior and Linker Design.
    Kumar H; Sobhia ME
    ACS Med Chem Lett; 2024 Aug; 15(8):1306-1318. PubMed ID: 39140051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Target protein localization and its impact on PROTAC-mediated degradation.
    Simpson LM; Glennie L; Brewer A; Zhao JF; Crooks J; Shpiro N; Sapkota GP
    Cell Chem Biol; 2022 Oct; 29(10):1482-1504.e7. PubMed ID: 36075213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Advances in PROTACs for Drug Targeted Protein Research.
    Yao T; Xiao H; Wang H; Xu X
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted protein degradation: elements of PROTAC design.
    Paiva SL; Crews CM
    Curr Opin Chem Biol; 2019 Jun; 50():111-119. PubMed ID: 31004963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mathematical Model for Covalent Proteolysis Targeting Chimeras: Thermodynamics and Kinetics Underlying Catalytic Efficiency.
    Chaudhry C
    J Med Chem; 2023 May; 66(9):6239-6250. PubMed ID: 37102218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SPR-Measured Dissociation Kinetics of PROTAC Ternary Complexes Influence Target Degradation Rate.
    Roy MJ; Winkler S; Hughes SJ; Whitworth C; Galant M; Farnaby W; Rumpel K; Ciulli A
    ACS Chem Biol; 2019 Mar; 14(3):361-368. PubMed ID: 30721025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Induced degradation of proteins by PROTACs and other strategies: towards promising drugs].
    Reboud-Ravaux M
    Biol Aujourdhui; 2021; 215(1-2):25-43. PubMed ID: 34397373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.